Insider filing · LENZ

Versant Venture Capital VI, L.P. sold $10.3M of LENZ Therapeutics (LENZ)

Executed Aug 15 2025, disclosed Aug 19 2025, 4 days later.

Returns are measured on stock purchases only.

VP Versant Venture Capital VI, L.P. 10% owner profile →

Versant Venture Capital VI, L.P. (10% owner) filed 4 Form 4 reports as a reporting entity in the past 24 months (0 purchases, 4 sales), most often in Monte Rosa Therapeutics, Inc. (GLUE). The largest single filing was $10.3M of LENZ (260,713 sh across 4 lots, as filed), executed Aug 15 2025.

LENZ LENZ LENZ · 11 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→